ProtekDuo as a bridge to lung transplant and heart‐lung transplant
Copyright policy )ProtekDuo as a bridge to lung transplant and heart‐lung transplant
AbstractRecent advances in technology have led to significantly greater use of extracorporeal membrane oxygenation (ECMO) as a bridge to lung transplantation with better outcomes. The novel ProtekDuo veno‐venous ECMO (CardiacAssist, Inc.) has gained significance as it facilitates effective decompression of the right heart in patients with acute decompensation, while also providing consistent and effective gas exchange by eliminating recirculation. Here, we report two cases of effectively using ProtekDuo veno‐venous ECMO: one case as a bridge to lung transplantation and another case as a bridge to heart‐lung transplantation.
- University System of Ohio United States
- Dignity Health United States
- Miami University United States
- Central University of Venezuela Venezuela
- Miami Transplant Institute United States
Extracorporeal Membrane Oxygenation, Treatment Outcome, Heart-Lung Transplantation, Humans, Lung Transplantation
Extracorporeal Membrane Oxygenation, Treatment Outcome, Heart-Lung Transplantation, Humans, Lung Transplantation
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).16 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!